Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Novadaq Technologies Inc. announced that Dr. Arun Menawat, President and Chief Executive Officer, will present at BioFinance 2009 on April 29 Novadaq Technologies Inc. (TSX:NDQ), a developer of real-time medical imaging systems and image guided therapies for the operating room, announced that Dr. Arun Menawat, President and Chief Executive Officer, will present at BioFinance 2009 on Wednesday, April 29 at 9:30 a.m. in the Trinity III Room at The Toronto Marriott Eaton Centre, Toronto, Ontario. Dr. Menawat will provide a corporate update, including a focus on the Company's plans to enter the minimally invasive surgical market and the upcoming introduction of its first endoscopic SPY imaging system.

BioFinance 2009 is the leading investor conference in Canada for the life sciences and cleantech industries. This three-day event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences and cleantech sectors. Presenting companies will span a range of industries including: medical devices, drug delivery, diagnostics, bioenergy, agriculture and food, industrial biotech, alternative energy and clean technologies.

About Novadaq Technologies Inc.

Novadaq develops and commercializes real-time imaging and image guidance systems for use in the operating room. Novadaq's SPY® Imaging System uniquely enables surgeons to visualize blood vessels, tumors, tumor margins, blood flow and the lymphatic system in real-time during surgery. This core technology is now being applied to and across multiple surgical markets such as cardiac, plastic and reconstructive, urological, general, micro and transplant. The PINPOINTTM System for endoscopic autofluorescence imaging is Novadaq's first minimally invasive product. For more information, please visit the company's website at http://www.novadaq.com.

Source: Novadaq Technologies Inc.